EUVIMEDEUVIMED entdecken
Open Access

Is neutropenic fever an obstacle to effective stem cell harvesting?

Semih Başcı, Ersin Bozan, Samet Yaman, Bahar Uncu Ulu, Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Ali Kılınç, Nurgül Özcan, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş

Asian Journal of Transfusion Science · 2024-01 · 18 (1) · 21-26

DOI: 10.4103/ajts.ajts_152_21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Transfusion Science, online erschienen am 28.09.2022. Verfasst von Semih Başcı und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A subset of patients’ adequate stem cell harvest is not achievable with a solitary use of granulocyte colony-stimulating agents (G-CSF). Generally, chemomobilization is employed for patients failing G-CSF and its most feared complication febrile neutropenia (FN). MATERIALS AND METHODS: Here, we aimed to investigate the impact of the FN in chemomobilization on apheresis outcomes and engraftment. One hundred and eighty-three patients with the diagnosis of lymphoma or myeloma who underwent chemomobilization between 2015 and 2020 were included in the study. RESULTS: Forty-three patients experienced FN. All patients received G-CSF. All myeloma patients were mobilized with 4 g/m 2 cyclophosphamide, but it was heterogeneous for lymphoma patients. The precollection blood counts, harvested CD34+ hematopoietic stem cells (HSCs)/kg, apheresis count, and engraftment durations were recorded. Preapheresis leukocyte and platelet were lower in the FN group ( P = 0,004 and P = 0,001). Peripheral CD34 HSCs and total harvested CD34 HSCs were similar among groups ( P = 0.25 and P = 0.9). More apheresis was needed in the FN group, but it was not significant ( P = 0.07). Undergoing ASCT was similar ( P = 0.7); however, platelet and neutrophil engraftment durations were slower in the FN group ( P = 0.05 and P = 0.001). CONCLUSION: Harvesting sufficient CD34+ HSCs from patients with FN is still feasible; however, FN treatment should begin promptly, and further apheresis sessions may be required.

Schlagwörter

Stichwörter der Autor:innen

Autologous stem cell transplantationchemomobilizationfebrile neutropenianeutropenic feverstem cell mobilization

Autor:innen und Institutionen

  • Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey.
  • Department of Clinical Biochemistry, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

Zitieren

APA

Başcı, S., Bozan, E., Yaman, S., Ulu, B. U., Bakırtaş, M., Yiğenoğlu, T. N., Kılınç, A., Özcan, N., Dal, M. S., Çakar, M. K., & Altuntaş, F. (2024). Is neutropenic fever an obstacle to effective stem cell harvesting?. Asian Journal of Transfusion Science, 18(1), 21-26. https://doi.org/10.4103/ajts.ajts_152_21

Vancouver

Başcı S, Bozan E, Yaman S, Ulu BU, Bakırtaş M, Yiğenoğlu TN, et al. Is neutropenic fever an obstacle to effective stem cell harvesting?. Asian Journal of Transfusion Science. 2024;18(1):21-26. doi:10.4103/ajts.ajts_152_21

BibTeX
@article{Bac2024,
  author = {Başcı, Semih and Bozan, Ersin and Yaman, Samet and Ulu, Bahar Uncu and Bakırtaş, Mehmet and Yiğenoğlu, Tuğçe Nur and Kılınç, Ali and Özcan, Nurgül and Dal, Mehmet Sinan and Çakar, Merih Kızıl and Altuntaş, Fevzi},
  title = {Is neutropenic fever an obstacle to effective stem cell harvesting?},
  journal = {Asian Journal of Transfusion Science},
  year = {2024},
  volume = {18},
  number = {1},
  pages = {21--26},
  doi = {10.4103/ajts.ajts_152_21}
}
Kostenlos starten →